Literature DB >> 15542750

Drug abuse trends among youth in the United States.

Joseph A Banken1.   

Abstract

Several years of survey data indicate that illicit drug use among U.S. youth was at its highest level in 1979. Generally, the use of some illicit drugs declined progressively throughout the 1980s, stabilized, and then decreased slightly. Reducing illicit drug use among U.S. youth continues to be a priority of federal, state, and local law enforcement agencies. The U.S. government tracks youth illicit drug use through three nationally representative surveys: National Household Survey on Drug Abuse, Monitoring the Future Study, and Youth Risk Behavior Survey. Other surveys include the Partnership Attitudes Tracking Study, conducted annually to assess youth and parental attitudes about drugs, and Drug Abuse Awareness Network (DAWN), a national surveillance system that monitors trends in drug-related emergency department visits and deaths. Although survey methods differ, similar trends in drug use are well documented by these surveys. Among American youth, illicit use of drugs such as tobacco, alcohol, inhalants, marijuana, LSD, cocaine, heroin, and methamphetamine has remained relatively stable. However, a noteworthy exception is the increased use of MDMA (methylenedioxymethamphetamine). The physical consequences of "club and recreational drug use" are evidenced in the increased numbers of emergency department visits, specifically those related to MDMA and gamma-hydroxy-butyrate use, which may represent a new and emerging trend in illicit drug use.

Entities:  

Mesh:

Year:  2004        PMID: 15542750     DOI: 10.1196/annals.1316.057

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  13 in total

1.  Contextual profiles of young adult ecstasy users: A multisite study.

Authors:  Ujjwal P Ramtekkar; Catherine W Striley; Linda B Cottler
Journal:  Addict Behav       Date:  2010-10-29       Impact factor: 3.913

Review 2.  Marijuana-based drugs: innovative therapeutics or designer drugs of abuse?

Authors:  Kathryn A Seely; Paul L Prather; Laura P James; Jeffery H Moran
Journal:  Mol Interv       Date:  2011-02

3.  Detection of stimulant drugs of abuse in maternal and neonatal hair.

Authors:  Facundo Garcia-Bournissen; Ben Rokach; Tatyana Karaskov; Joey Gareri; Gideon Koren
Journal:  Forensic Sci Med Pathol       Date:  2007-09-05       Impact factor: 2.007

4.  Increased drug use and STI risk with injection drug use among HIV-seronegative heterosexual methamphetamine users.

Authors:  W Susan Cheng; Richard S Garfein; Shirley J Semple; Steffanie A Strathdee; James K Zians; Thomas L Patterson
Journal:  J Psychoactive Drugs       Date:  2010-03

5.  Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands.

Authors:  Krishna C Chimalakonda; Kathryn A Seely; Stacie M Bratton; Lisa K Brents; Cindy L Moran; Gregory W Endres; Laura P James; Paul F Hollenberg; Paul L Prather; Anna Radominska-Pandya; Jeffery H Moran
Journal:  Drug Metab Dispos       Date:  2012-08-17       Impact factor: 3.922

6.  Neonatal 3,4-methylenedioxymethamphetamine (MDMA) exposure alters neuronal protein kinase A activity, serotonin and dopamine content, and [35S]GTPgammaS binding in adult rats.

Authors:  Cynthia A Crawford; Michael T Williams; Jodie L Kohutek; Fiona Y Choi; Shelly T Yoshida; Sanders A McDougall; Charles V Vorhees
Journal:  Brain Res       Date:  2006-02-14       Impact factor: 3.252

7.  Age-dependent differences in sensitivity and sensitization to cannabinoids and 'club drugs' in male adolescent and adult rats.

Authors:  Jenny L Wiley; Rhys L Evans; Darren B Grainger; Katherine L Nicholson
Journal:  Addict Biol       Date:  2007-09-11       Impact factor: 4.280

Review 8.  3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings.

Authors:  Michael H Baumann; Xiaoying Wang; Richard B Rothman
Journal:  Psychopharmacology (Berl)       Date:  2006-03-16       Impact factor: 4.530

9.  Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA).

Authors:  Michael H Baumann; Richard B Rothman
Journal:  Int Rev Neurobiol       Date:  2009       Impact factor: 3.230

10.  Behavioral and social correlates of methamphetamine use in a population-based sample of early and later adolescents.

Authors:  Dennis Embry; Martin Hankins; Anthony Biglan; Shawn Boles
Journal:  Addict Behav       Date:  2008-11-27       Impact factor: 3.913

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.